CONCORDBIOBSEConcord Biotech LtdLowNeutral
Announced Tue, 7 Jul · 15:46 IST

41st AGM notice: Rs 7.55 dividend, new independent director, loan limit raised to Rs 500 Cr

Board & Shareholder Meetings View source PDF

CONCORDBIO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+3.2%1-day move
₹1270.00
prior close
₹1279.90
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.7+1.8+2.5+0.2+3.2+2.6+6.3+5.0+5.8+5.4
Up moveDown movePending
AI summary

Concord Biotech will hold its 41st AGM on July 31, 2026 at 12 noon via video conferencing. Key agenda items: adoption of FY26 audited financial statements, declaration of Rs 7.55 per share dividend (755% on face value of Rs 1), re-appointment of Mr. Ankur Vaid who retires by rotation, appointment of Mrs. Ekta Gupta as Independent Director for 5 years from June 01, 2026, raising the Section 185 limit for loans and guarantees to subsidiaries, associates and joint ventures from Rs 115 Cr to Rs 500 Cr, and ratification of Rs 3.70 lakh remuneration for M/s Dalwadi and Associates as Cost Auditors for FY27. Record date is July 24, 2026. Remote e-voting runs July 28 to July 30, 2026.

Likely market impact

Positive: Rs 7.55 dividend confirmed for FY26; quadrupled Rs 500 Cr inter-company funding limit signals expansion plans for subsidiaries and JVs. New independent director strengthens board.